Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...
Twist Bioscience (TWST) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
TD Cowen analyst Brendan Smith maintained a Buy rating on Twist Bioscience (TWST – Research Report) today and set a price target of $58.00. The company’s shares closed yesterday at $39.68.
Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback